2016
DOI: 10.3109/02699052.2016.1160151
|View full text |Cite|
|
Sign up to set email alerts
|

Protective effects of PARP inhibitor, PJ34, is related to down-regulation of calpain and NF-κB in a mouse model of TBI

Abstract: PARP inhibition by PJ34 suppresses the over-activation of calpain and the production of inflammatory factors that are caused by NF-κB activation and it improves neurological functioning, decreases the contusion volume and attenuates neuronal cell death in a mouse model of CCI.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 69 publications
0
3
0
Order By: Relevance
“…Therefore, strong activation of PARP-1 due to TBI may convert PARP-1 from being an agent of DNA repair to a trigger of neuronal injury and neuroinflammation. In support of PARP-1 contributing to CNS damage in TBI, PARP-1 inhibition reduces microglial activation and functional impairment and increases neuron survival in experimental models of TBI 3840 . The activation of mGluR5 decreases microglial activation and reduces microglial release of pro-inflammatory factors, which reduces neuronal loss and improves functional recovery after experimental TBI 41 .…”
Section: Traumatic Brain Injury-induced Neuroinflammationmentioning
confidence: 95%
See 1 more Smart Citation
“…Therefore, strong activation of PARP-1 due to TBI may convert PARP-1 from being an agent of DNA repair to a trigger of neuronal injury and neuroinflammation. In support of PARP-1 contributing to CNS damage in TBI, PARP-1 inhibition reduces microglial activation and functional impairment and increases neuron survival in experimental models of TBI 3840 . The activation of mGluR5 decreases microglial activation and reduces microglial release of pro-inflammatory factors, which reduces neuronal loss and improves functional recovery after experimental TBI 41 .…”
Section: Traumatic Brain Injury-induced Neuroinflammationmentioning
confidence: 95%
“…Additionally, PARP-1 may initiate neuronal death through the release of apoptosis-inducing factor and impairing mitochondrial function and glycolytic metabolism 32, 35, 36 . PARP-1-dependent nuclear factor-kappa-B activation induces the expression of pro-inflammatory genes and activates microglia 37, 38 . Activated microglia release multiple types of neurotoxic molecules.…”
Section: Traumatic Brain Injury-induced Neuroinflammationmentioning
confidence: 99%
“…Similarly, post-traumatic administration of the novel p53 inactivator pifithrin-α oxygen analogue offers protection against brain injury-induced neuronal apoptotic loss in hippocampal and improves cognitive deficits in rats [ 293 ]. PARP inhibitors (such as PJ34, CV1013, GPI 6150 etc .,) have also shown beneficial effects in TBI mediated cell death and neurological outcome in preclinical as well as clinical studies [ 294 , 295 ]. Although, several other classes of molecules (such as inhibitors of toll-like receptor pathway/mTOR pathway/p53 etc .,) have been tested for their therapeutic potential in brain injury-induced secondary cell death and apoptosis, details description of each is out of scope within this manuscript [ 296 ].…”
Section: Therapeutic Approaches In the Treatment Of Tbimentioning
confidence: 99%